You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Don't Miss Hypophosphatemic Bone Disease!

  • Authors: Karl Insogna, MD; Erik A. Imel, MD; Leanne Ward, MD, FRCPC
  • CME / ABIM MOC Released: 11/4/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 11/4/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for diabetologists, endocrinologists, rheumatologists, and nephrologists. 

The goal of this activity is to educate physicians on the diagnosis and treatment of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding
    • The treatment of patients with XLH
    • A new treatment option for TIO
  • Have greater competence related to
    • The diagnosis of patients presenting with hypophosphatemia


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Karl Insogna, MD

    Ensign Professor of Medicine, Department of Internal Medicine/Endocrinology
    Director, Yale Bone Center
    Associate Director, Yale Center for X-Linked Hypophosphatemia, Endocrinology
    Yale School of Medicine
    New Haven, Connecticut, United States

    Disclosures

    Disclosure: Karl Insogna, MD, has disclosed the following relevant financial relationships: 
    Received grants for clinical research from: Ultragenyx Pharmaceutical

Panelists

  • Erik A. Imel, MD

    Associate Professor of Medicine and Pediatrics
    Riley Hospital for Children at Indiana University Health
    Endocrinology/Internal Medicine/Pediatrics
    Indiana University School of Medicine
    Indiana Center for Musculoskeletal Health
    Indianapolis, Indiana, United States
     

    Disclosures

    Disclosure: Erik A. Imel, MD, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: Ultragenyx Pharmaceutical
    Received grants for clinical research from: Ultragenyx Pharmaceutical
     

  • Leanne Ward, MD, FRCPC

    Tier 1 Research Chair in Pediatric Bone Disorders
    Professor of Pediatrics
    University of Ottawa
    Medical Director 
    CHEO Genetic and Metabolic Bone Disease Clinic
    Scientific Director 
    Ottawa Pediatric Bone Health Research Group 
    Ottawa, Ontario, Canada

    Disclosures

    Disclosure: Leanne Ward, MD, FRCPC, has disclosed the following relevant financial relationships: 
    Served as an advisor or consultant for: Ultragenyx Pharmaceutical, with funds to Dr Ward's institution
    Received grants for clinical research from: Ultragenyx Pharmaceutical, with funds to Dr Ward's institution

Editors

  • Kathy Merlo

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Kathy Merlo has disclosed no relevant financial relationships.

  • Rosylyn Blumenthal, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Rosylyn Blumenthal, PhD, has disclosed no relevant financial relationships.

  • Heather Lewin, MAT

    Associate Director, Medscape, LLC

    Disclosures

    Disclosure: Heather Lewin, MAT, has disclosed no relevant financial relationships.

Reviewers

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Don't Miss Hypophosphatemic Bone Disease!

Authors: Karl Insogna, MD; Erik A. Imel, MD; Leanne Ward, MD, FRCPCFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 11/4/2020

Valid for credit through: 11/4/2021

processing....

Educational Impact Challenge

The goal of this activity is to educate physicians on the diagnosis and treatment of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO).

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print